Abaxis Inc  

(Public, NASDAQ:ABAX)   Watch this stock  
Find more results for ABAX
47.75
+0.69 (1.47%)
Aug 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 46.91 - 47.90
52 week 32.11 - 48.46
Open 47.19
Vol / Avg. 84,658.00/198,606.00
Mkt cap 1.08B
P/E 68.91
Div/yield 0.10/0.84
EPS 0.69
Shares 22.52M
Beta 0.98
Inst. own 104%
Oct 20, 2014
Q2 2015 Abaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 9, 2014
Abaxis Inc at CL King & Associates Inc Best Ideas Conference - 12:30PM EDT - Add to calendar
Jul 24, 2014
Q1 2015 Abaxis Inc Earnings Call - Webcast
Jul 24, 2014
Q1 2015 ABAXIS INC Earnings Release
Jun 2, 2014
ABAXIS INC at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 9.93% 8.25%
Operating margin 15.67% 12.10%
EBITD margin - 16.42%
Return on average assets 8.52% 6.77%
Return on average equity 9.67% 7.67%
Employees 520 -
CDP Score - -

Address

3240 Whipple Road
UNION CITY, CA 94587
United States - Map
+1-510-6756500 (Phone)
+1-510-4416150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. The Company�s segments include the medical market and the veterinary market. The Company has developed a blood analysis system incorporating all of these criteria into a 5.1 kilogram (11.2 pounds) portable analyzer and a series of menu-specific, multi-test single-use reagent discs. Abaxis markets its blood chemistry analyzers in the medical market and in the veterinary market. The Company markets the blood analysis system in the medical market under the name Piccolo Xpress. It markets the blood analysis system in the veterinary market under the name VetScan VS2.

Officers and directors

Clinton H. Severson Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alberto R. Santa Ines Chief Financial Officer, Vice President - Finance
Age: 66
Bio & Compensation  - Reuters
Donald P. Wood Chief Operations Officer
Age: 61
Bio & Compensation  - Reuters
Kenneth P. Aron Ph.D. Chief Technology Officer
Age: 60
Bio & Compensation  - Reuters
Craig Tockman Vice President, Sales & Marketing � NAAH
Bio & Compensation  - Reuters
Vladimir E. Ostoich Ph.D. Vice President - Marketing for Pacific Rim, Vice President - Government Affairs
Age: 67
Bio & Compensation  - Reuters
Achim Henkel Vice President - Marketing for Pacific Rim, Vice President - Government Affairs, Managing Director of Abaxis Europe GmbH
Age: 55
Bio & Compensation  - Reuters
Vernon Edward Altman Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard J. Bastiani Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters
Michael D. Casey Independent Director
Age: 68
Bio & Compensation  - Reuters